Efficacy of Lophira alata Leaf Extract and its Combination with Artesunate in Mice Prior Exposed to Plasmodium berghei

Abstract

Enhanced antimalarial activity of plant extracts used for treatment of malaria in endemic areas is attributed to partial immunity gained by prior infection. This suggests synergy between immunity and extract activity in treatment. Testing this hypothesis, rodent malaria was used to determine efficacy of Lophira alata leaf extracts in treating malaria in prior infected mice. One round of P. berghei infection and Pyrimethamine drug-cure was used to establish partial immunity in mice. Previously Exposed Mice (PEM) and Previously Unexposed Mice (PUM) mice challenged with P. berghei were used to determine influence of partial antimalarial immunity on efficacy of L. alata leaf extracts, administered alone or in combination with Artesunate (ART) in malaria treatment. There was a significant reduction in parasitemia in PEM when compared to PUM animals (P<0.001) irrespective of treatment regimen. Administration of L. alata combined with ART significantly reduced parasitemia (P<0.0032) and prolonged (P=0.0109) survival than when L. alata was administered alone in infected mice. These findings suggest that the action of L. alata in treating malaria infections in a murine model is enhanced by prior exposure to the malaria parasite. Thus the requirements of using plants in treating malaria in endemic populations may differ for those used in western systems, where trials are carried out with non-immune cohorts. Combining artemisinin derivatives and medicinal plants in malaria exposed populations may provide an alternative control measure in endemic regions and may justify the continued use of these plants by indigenous populations in treating malaria.

Key words

Lophira alata - antiparasitic drugs - infectious diseases - drug research

• References

• 1 Alonso PL, Tanner M. Public health challenges and prospects for malaria control and elimination. Nature Med 2013; 19: 150-155
• 2 WHO. World malaria report 2015. Geneva: World Health Organization;
• 3 Bhattarai A, Ali AS, Kachur SP. et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 2007; 6: e309
• 4 Noedl H, Se Y, Schaecher K. et al. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med 2008; 359: 2619 -2620
• 5 Dondorp AM, Nosten F, Yi P. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009; 361: 455-467
• 6 MalariaGEN Plasmodium falciparum Community Project. Genomic epidemiology of artemisinin resistant malaria. Elife 2016; DOI: 10.7554/elife.08714.
• 7 Rasoanaivo P, Petitjean A, Ratsimamanga-Urverg S. Medicinal plants used to treat malaria in Madagascar. J Ethnopharmacol 1992; 37: 117-127
• 8 Martinelli A, Rodrigues LA, Cravo P. Plasmodium chabaudi: Efficacy of artemisinin+curcumin combination treatment on a clone selected for artemisinin resistance in mice. Exp Parasitol 2008; 119: 304-307
• 9 Maranz S. An Alternative Paradigm for the Role of Antimalarial Plants in Africa. Scientific World Journal 2012; DOI: 10.1100/2012/978913.
• 10 Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy. Microbiol Rev 1996; 60: 301-315
• 11 Khalid SA, Farouk A, Geary TG. et al. Potential antimalarial candidates from African plants: An in vitro approach using Plasmodium falciparum . J Ethnopharmacol 1986; 15: 201-209
• 12 Soh N, Benoit-Vical F. Are West African plants a source of future antimalarial drugs?. J Ethnopharmacol 2007; 114: 130-140
• 13 Pillay P, Maharaj VJ, Smith PJ. Investigating South African plants as a source of new antimalarial drugs. J Ethnopharmacol 2008; 119: 438-454
• 14 Falade MO, Akinboye DO, Gbotosho GO. et al. In Vitro and In Vivo Antimalarial Activity of Ficus thonningii Blume (Moraceae) and Lophira alata Banks (Ochnaceae), Identified from the Ethnomedicine of the Nigerian Middle Belt. J Parasitol Res 2014; DOI: 10.1155/2014/972853.
• 15 Guantai E. Chibale How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?. Malar J. 2011; 10 (Suppl. 01) S2
• 16 Talwar GP, Shah S, Mukherjee S. et al. Induced termination of pregnancy by purified extracts of Azadirachta Indica (Neem): mechanisms involved. Am J Reprod Immunol 1997; 37: 485-491
• 17 Willcox ML, Bodeker G. Traditional herbal medicines for malaria. BMJ 2004; 329: 1156-1159
• 18 Kirby GC. Medicinal plants and the control of parasites: Medicinal plants and the control of protozoal disease, with particular reference to malaria. Trans R Soc Trop Med Hyg 1996; 90: 605-609
• 19 Munoz V, Sauvain M, Bourdy G. et al. A search for natural bioactive compounds in Bolivia through a multidisciplinary approach Part I. Evaluation of the antimalarial activity of plants used by the Chacobo Indians. J Ethnopharmacol 2000; 69: 127-137
• 20 Doolan DI, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev 2009; 22: 13-36
• 21 Peters W. Chemotherapy and drug resistance in malaria. 2nd edn. London: Academic Press; 1987
• 22 Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis 2001; 184: 770-776
• 23 Alker AP, Lim P, Sem R. et al. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian–Thai border. Am J Trop Med Hyg 2007; 76: 641-647
• 24 Price RN, Uhlemann AC, Brockman A. et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004; 364: 438-447
• 25 Djimde A, Doumbo OK, Cortese JF. et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001; 344: 257-263
• 26 Adagu SI, Okoyeh JN, Lege-Oguntoye L. et al. Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine. J Trop Med Hyg 1995; 98: 296-298
• 27 Cravo P, Culleton R, Hunt P. et al. Antimalaria drugs clear resistant parasites from partially immune hosts. Antimicrobial Agents Chemother 2001; 45: 2897-2901
• 28 Cheesman S, Raza A, Carter R. Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in Mice. 2006; 74: 2996-3001
• 29 Long TT, Nakazawa S, Huaman MC. et al. Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria. Clin Diagn Lab Immunol 2002; 9: 933-934
• 30 Ajaiyeoba E, Ashidi J, Abiodun O. et al. Antimalarial Ethnobotany: In vitro Antiplasmodial Activity of Seven Plants Identified in the Nigerian Middle Belt. Pharmaceutical Biology 2004; 42: 588-591
• 31 Jarra W, Brown KN. Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter-and intra- species specificity of immunity induced by infection. Parasite Immunol 1985; 7: 595-606
• 32 Djimde AA, Doumbo OK, Traore O. et al. Clearance of Drug-resistant Parasites as a Model for Protective Immunity in Plasmodium falciparum Malaria. Am. J. Trop. Med. Hyg 2003; 69: 558-563
• 33 Zhu X, Pan Y, Zheng L. et al. Polysaccharides from the Chinese medicinal herb Achyranthes bidentata enhance anti-malarial immunity during Plasmodium yoelii 17XL infection in mice. Malar J 2012; 11: 49
• 34 Evans KJ, Hansen DS, van Rooijen N. et al. Severe malaria anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood 2006; 107: 1192-1199
• 35 Achtman AH, Stephens R, Cadman ET. et al. Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi. Parasite Immunol 2007; 29: 435-444
• 36 Ryley JF, Peters W. The antimalarial activity of some quinone esters. Ann Trop Med Parasitol 1970; 84: 209-222
• 37 Vivas L, Rattray L, Stewart L. et al. Anti-malarial efficacy of pyronaridine and artesunate in combination in invitro and in vivo. Acta Trop. 2008; 105: 222-228
• 38 Rogerson SJ, Wijesinghe RS, Meshnick SR. Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria. Lancet Infect Dis 2010; 10: 51-59
• 39 Muregi FW. Antimalarial drugs and their useful therapeutic lives: Rational drug design lessons from pleiotropic action of quinolines and artemisinins. Curr Drug Discov Technol 2010; 7: 280-316
• 40 White NJ. Qinghaosu (artemisinin): the price of success. Science 2008; 320: 330-334
• 41 Ishih A, Suzuki T, Watanabe M. et al. Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR Mice. Phytother Res 2003; 17: 1234-1236
• 42 Nanadakumar DN, Nagaraj VA, Vathsala PG. et al. Curcumin artemisinin combination therapy for malaria. Antimicrob Agents Chem 2006; 50: 1859-1860
• 43 Rajan A, Bagai U, Chandel S. Effect of artesunate based combination therapy with homeopathic medicine china on liver and kidney of Plasmodium berghei infected mice. J Parasit Dis 2013; 37: 62-67
• 44 Rasoanaivo P, Wright CW, Willcox ML. et al. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malaria J 2011; 10 (Suppl. 01) S4